Micron Technology to Report Fiscal First Quarter Results on December 17, 2025

(NASDAQ:MU), BOISE, Idaho, Nov. 19, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 17, 2025, at 2:30 p.m. Mountain time. The call will be webcast live at http://investors.micron.com/. Webcast replays of presentations can be accessed from Micron's Investor Relations […]

Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date

(NASDAQ:FIVE), PHILADELPHIA, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for kids, today announced that its financial results for the third quarter of fiscal 2025 will be released after market close on Wednesday, December 3, 2025. The company will host a conference call at 4:30 p.m. Eastern

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:BBIO), PALO ALTO, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on November 17, 2025, the compensation committee of BridgeBio's board of directors approved equity grants to 12 new employees in restricted stock units

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

(NASDAQ:CARL), CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Healthcare conference on Wednesday, December 3rd at 9:00-9:25 am ET in New York, NY. During the conference, Carlsmed Management

ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025

TEL AVIV, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) — ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors, today announced an abstract including updated interim results from ENLIGHTED, the Company's ongoing Phase 3 study of Padeliporfin VTP treatment of patients with low-grade

Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date

Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date GlobeNewswire November 19, 2025 PHILADELPHIA, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for kids, today announced that its financial results for the third quarter of fiscal 2025 will be released after market close

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 19, 2025 CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Healthcare conference on Wednesday,

ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025

ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025 GlobeNewswire November 19, 2025 TEL AVIV, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) — ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of

Capital Southwest Announces Monthly Regular Dividends for the Quarter Ending March 31, 2026 and Quarterly Supplemental Dividend Payable on March 31, 2026

Capital Southwest Announces Monthly Regular Dividends for the Quarter Ending March 31, 2026 and Quarterly Supplemental Dividend Payable on March 31, 2026 GlobeNewswire November 19, 2025 DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions

Micron Technology to Report Fiscal First Quarter Results on December 17, 2025

Micron Technology to Report Fiscal First Quarter Results on December 17, 2025 GlobeNewswire November 19, 2025 BOISE, Idaho, Nov. 19, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 17, 2025, at 2:30 p.m. Mountain time. The call will

Scroll to Top